Desonate (Desonide Topical) - Indications and Dosage

INDICATIONS AND USAGE

Desonate Gel is indicated for the treatment of mild to moderate atopic dermatitis in patients 3 months of age and older. Patients should be instructed to use Desonate Gel for the minimum amount of time as necessary to achieve the desired results because of the potential for Desonate Gel to suppress the hypothalamic-pituitary-adrenal (HPA) axis (see PRECAUTIONS). Treatment should not exceed 4 consecutive weeks.

DOSAGE AND ADMINISTRATION

Desonate Gel should be applied as a thin layer to the affected areas two times daily and rubbed in gently. Therapy should be discontinued when control is achieved. If no improvement is seen within 4 weeks, reassessment of diagnosis may be necessary. Treatment beyond 4 consecutive weeks is not recommended.

Desonate Gel should not be used with occlusive dressings.

HOW SUPPLIED

Desonate Gel is supplied in:
3.5g Sample-Not for Sale (NDC 67402-050-03)
60g (NDC 67402-050-60) tubes

STORAGE CONDITIONS: Store at controlled room temperature: 25°C (77°F), excursions permitted between 15° - 30°C (59°– 86°F).

Avoid contact with eyes or other mucous membranes
Keep out of reach of children

CAUTION: Federal law prohibits dispensing without a prescription.

________________________________________________________________________

Manufactured by:
CPL,
Buffalo, New York 14213
Distributed by:
SkinMedica
Carlsbad, CA 92010
866-867-0110; www.skinmedica.com

The Hydrogel Technology logo is a trademark of Dow Pharmaceutical Sciences, Inc.

Desonate is a trademark of SkinMedica.

03-6083 (flat)
03-6082 (folded)
10/2006